According to a new report by, the Diabetes Injection Pens Market size is expected to register with a CAGR of over 8.5% over the forecast period.
Insulin pen needles are used along with insulin pens for injecting insulin. They come in a variety of needle lengths and diameters and are individually wrapped to keep them sterile. Diabetic Insulin pens resemble that of a pen, and their working is similar to that of insulin syringes. They come in both reusable and disposable form. Reusable models use a cartridge filled with insulin. Disposable pens come pre-filled with insulin. Chief advantages of insulin pens include memory storage and convenience of use.
Since the time of their inception, diabetes injection pens have witnessed drastic evolution. This is mainly due to consistent research activities by academic and scientific organizations and pharmaceutical companies. Technological interventions have made the market steeply competitive. As the number of players, the pressure to enhance sales figures is also on the rise. These spurs players in the diabetic injection pens market to roll out new or upgraded products.
Request a Sample@ https://www.qyresearchmedical.com/sample/119486
Consequently, companies are continuously able to provide something new to the healthcare providers, and the prescription loyalty is maintained. While investments to develop new products remain consistent, companies in the diabetic injection pens market are also seeking new patented technology. This way, they save time on research and will directly focus on scaling up or testing.
The idea behind diabetic injection pens is convenience. As companies implement new ideas in their products, they recognize the essence of monitoring consumer behavior. This helps players in the diabetes injection pens market to focus on developing products that are more user-friendly. By convenience, the products are designed to make rendering insulin shots a task that will require only 10 seconds. The idea is to eliminate dependence to deliver medicine.
Ironically while technology will augment the growth of the global diabetic injection pens market, it will also limit the growth of the market in some ways. For instance, the same pharmaceutical companies or those manufacturing medical devices are also the once that are promoting the usage of wearable devices to keep track of health. Moreover, patients are becoming more aware and are determined to get rid of insulin. They are also controlling their blood sugar levels, and thus aim to switch back to tablets or reduce the dosage. This will somewhat restrain the growth of the diabetic injection pens market.
However, the rising diabetic population due to sedentary lifestyles will go a long way in countering the effects of technology and help players remain relevant in the global diabetic injection pens market.
The market is segmented on the basis of type, usage, distribution channel, and region. On the basis of type, the market is segmented as disposable and reusable injection pens. The disposable injection pens segment is anticipated to register the highest CAGR over the forecast period. The high growth of this segment can be credited to the benefits of disposable pens, which include portability, ease of use, and low possibility of infection.
Based on distribution channel, the global market is categorized into hospital pharmacy, retail pharmacy, online sales, and diabetes clinics. The hospital and retail pharmacy segments held a considerable share of the market, but with the rise of online sales channels, this segment is also expected to register the high CAGR during the forecast period. Due to the growing demand for self-administration drug delivery devices and the growing prevalence of chronic diseases, diabetes clinics are also witnessing increased business.
North America accounted for the largest market share in 2019, followed by Europe. The presence of major medical devices company and diabetes management in these two regions has driven the growth in these regions over the past couple of decades. Moreover, increasing awareness about diabetes self-management education would also augment market growth. The Asia-Pacific region is projected to grow at a swifter rate compared to other regions, due to rising per capita healthcare expenditure, growing healthcare infrastructure, and increasing awareness about injection pens in the primary markets of APAC such as India, China, and Southeast Asian countries.
The major players in the diabetes injection pens market are Novo Nordisk (Denmark), Sanofi (France), F.Hoffman-La Roche (Switzerland), Eli Lilly (U.S.), Merck (U.S.), AstraZeneca (U.K.), Pfizer (U.S.), Ypsomed (Switzerland), Becton Dickinson and Company (U.S.), Owen Mumford (U.K.), Novartis (Switzerland), and Haselmeier (Switzerland).
Segments covered in the report:
By Product Type (Revenue, USD Million; 2023-2032)
- Insulin Pens
- Pen Needles
By Usage (Revenue, USD Million; 2023-2032)
- Reusable Pens
- Disposable Pens
By Distribution Channel (Revenue, USD Million; 2023-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
By Region (Revenue, USD Million; 2023-2032)
- North America
- Rest of the Europe
- Rest of Asia
- Latin America (LATAM)
- Rest of LATAM
- Rest of World
- Australia & New Zealand
- South Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119486/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: